IPC분류정보
| 국가/구분 |
United States(US) Patent
등록
|
| 국제특허분류(IPC7판) |
|
| 출원번호 |
US-0070217
(2005-03-03)
|
| 등록번호 |
US-8729202
(2014-05-20)
|
| 우선권정보 |
AU-2004901111 (2004-03-03) |
|
발명자
/ 주소 |
- Mayadunne, Roshan Tyrrel Anton
- Adhikari, Raju
- Gunatillake, Pathiraja Arachchillage
|
| 출원인 / 주소 |
- Polynovo Biomaterials Pty Limited
|
| 대리인 / 주소 |
Novak Druce Connolly Bove + Quigg LLP
|
| 인용정보 |
피인용 횟수 :
0 인용 특허 :
32 |
초록
▼
The present invention provides a biocompatible polymer composition for use in biomedical applications comprising a base molecule, a linker molecule and at least one initiator compound, said base molecule having at least two differing functionalities, and said linker molecule having a functionality r
The present invention provides a biocompatible polymer composition for use in biomedical applications comprising a base molecule, a linker molecule and at least one initiator compound, said base molecule having at least two differing functionalities, and said linker molecule having a functionality reactive with at least one functionality of said base molecule, the first of said at least two functionalities of said base molecule enabling a first curing stage of said polymer composition by reaction with said linker molecule, and the second and any further functionality of said base molecule enabling second and further curing stages of said polymer composition, said first, second and any further curing stages being capable of activation simultaneously or independently of each other as required.
대표청구항
▼
1. A biocompatible, biodegradable prepolymer for use in biomedical applications comprising the reaction product of: (a) a base molecule having a molecular weight of 155 or less and having at least two differing functionalities; wherein at least one of the functionalities is acrylate and the at least
1. A biocompatible, biodegradable prepolymer for use in biomedical applications comprising the reaction product of: (a) a base molecule having a molecular weight of 155 or less and having at least two differing functionalities; wherein at least one of the functionalities is acrylate and the at least one other functionality is one or more isocyanate groups;(b) a linker molecule having a molecular weight of 300 or less and having a functionality reactive with at least one of said functionalities of said base molecule; said reaction product being the result of a first curing stage wherein the first of said at least two functionalities of said base molecule reacts with the functionality of said linker molecule to form said prepolymer, and wherein said prepolymer flows and is injectable. 2. A biocompatible, biodegradable polymer composition for use in biomedical applications comprising the reaction product of claim 1 having the second and any further functionality of said base molecule activated by at least one initiator compound in a second and optionally further curing stage. 3. The biocompatible, biodegradable polymer composition according to claim 2, additionally comprising one or more of the group consisting of radical inhibitor, sensitizer, promoter, dispersant, porogen, catalyst, biological components, bioactive molecules, hydroxyapatite, calcium phosphate, and surfactant. 4. A cured biocompatible, biodegradable polymeric end product for use in biomedical applications comprising the reaction product of: (a) a base molecule having a molecular weight of 155 or less and having at least two differing functionalities; wherein at least one of the functionalities is acrylate and the at least one other functionality is one or more isocyanate groups;(b) a linker molecule having a molecular weight of 300 or less and having a functionality reactive with at least one of said functionalities of said base molecule;(c) at least one initiator compound; said end product being the result of a first curing stage wherein the first of said at least two functionalities of said base molecule reacts with the functionality of said linker molecule to form the prepolymer according to claim 1, and a second curing stage and optionally further curing stages wherein said initiator compound is activated to affect free radical polymerization of at least said second functionality of said base molecule. 5. An article of manufacture comprising the biocompatible, biodegradable polymer composition according to claim 2. 6. The article of claim 5 wherein the article is a biomedical implant, a bioadhesive, a dental or periodontal cement composition, a dry delivery vehicle composition, or an aqueous emulsion for the delivery of cells, growth factors or bioactive moieties including biopharmaceuticals and drugs. 7. An article of manufacture comprising the biocompatible, biodegradable prepolymer according to claim 1. 8. The article of claim 7 wherein the article is a biomedical implant, a bioadhesive, a dental or periodontal cement composition, a dry delivery vehicle composition, or an aqueous emulsion for the delivery of cells, growth factors or bioactive moieties including biopharmaceuticals and drugs. 9. An article of manufacture comprising the cured biocompatible biodegradable prepolymer composition according to claim 4. 10. The article of claim 9 wherein the article is a biomedical implant, a bioadhesive, a dental or periodontal cement composition, or a dry delivery vehicle composition. 11. The biocompatible, biodegradable prepolymer according to claim 1, wherein the base molecule is isocyanato ethyl methacrylate or isocyanato ethyl acrylate. 12. The biocompatible, biodegradable polymer composition according to claim 2, wherein the base molecule is isocyanato ethyl methacrylate or isocyanato ethyl acrylate. 13. The cured biocompatible, biodegradable polymeric end product according to claim 4, wherein the base molecule is isocyanato ethyl methacrylate or isocyanato ethyl acrylate.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.